Osteoarthritis, Knee Chronic Pain
Conditions
Interventions
This is a randomized controlled clinical trial with three arms and double-blind design. A total of 108 participants who meet the eligibility criteria will be randomly allocated to one of three treatme
Sponsors
Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad
Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad
Eligibility
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: Both genders; Patients diagnosed with advanced knee OA (Ahlback >3); Age between 60 and 80 years; Chronic pain for more than 6 months, with an intensity =5 on the Visual Analog Scale (VAS, graded from 0 to 10); Access to a smartphone with WhatsApp and the cognitive ability to answer questions on this application; Patients on the waiting list for total knee arthroplasty (TKA) at INTO
Exclusion criteria
Exclusion criteria: Angular deformities >10° in the coronal plane or >10° in the sagittal plane; Morbid obesity; Uncontrolled diabetes; Coagulopathies; Psychiatric disorders or chronic use of anxiolytics/opioids; History of articular infection, previous surgery, or aritcular injection of corticosteroids/hyaluronic acid in the last 3 months; Presence of neoplasia in the affected knee, pacemaker, or implanted neurostimulators; Positive result on the neuropathic pain questionnaire (DN4), according to Santos et al. (2010) and Mayoral et al. (2018)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An improvement in functional scores and a greater reduction in pain levels, as measured by the Visual Analog Scale (VAS), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the Knee injury and Osteoarthritis Outcome Score - Junior (KOOS JR), is expected among participants undergoing radiofrequency treatment (pulsed or continuous) compared to the control group. Data collected at baseline (pre-intervention) and 1 month after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate functional improvement in the three groups, measured by WOMAC and KOOS JR, over time. Data collected 1, 3, 6, and 12 months after the intervention.;To evaluate the improvement in pain perception in the three groups, measured by the Visual Analog Scale, over time. Data collected 1, 3, 6, and 12 months after the intervention. | — |
Countries
BR
Contacts
Public ContactJose de Faria
Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad
Outcome results
None listed